Shionogi & Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Shionogi & Co., Ltd.

Shionogi & Co., Ltd. (塩野義製薬株式会社, 4507), Pharmaceutical. 15 cross-shareholdings, a board of 11 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100Z43Z, filed 2026-09-25. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31335.1114.21,150.6126.25115.005,693
2023-03-31426.7185.01,311.8207.10135.005,680
2024-03-31410.1162.01,416.9186.17160.004,959
2025-03-31438.3170.41,535.3200.36118.004,955
2026-03-31499.7205.22,576.9241.1171.006,223

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Sumitomo Mitsui Financial Group, Inc.3,452,43017.30.1
TOHO HOLDINGS CO.,LTD.3,500,11216.75.4
KISSEI PHARMACEUTICAL CO., LTD.914,0004.22.2
MEDIPAL HOLDINGS CORPORATION1,271,6053.70.6
StemRIM Inc.4,650,0001.47.4
KANEKA CORPORATION266,6001.30.4
ONO PHARMACEUTICAL CO., LTD.344,0950.90.1
VITAL KSK HOLDINGS,INC.475,0000.71.0
HOKUYAKU TAKEYAMA Holdings,Inc.367,5300.31.8
MS&AD Insurance Group Holdings, Inc.65,4330.30.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown